Matches in Nanopublications for { ?s ?p "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 20 of
20
with 100 items per page.
- NP757651.RAADBxHGjq4EnLllnPjlG7KC9zriUqa9pALz3oDsT7TG4130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP757651.RAADBxHGjq4EnLllnPjlG7KC9zriUqa9pALz3oDsT7TG4130_provenance.
- NP928595.RA_wvc3RNX3No6Z8TbmR7suMD5AG_VLBLVgpJAIMEhYlM130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928595.RA_wvc3RNX3No6Z8TbmR7suMD5AG_VLBLVgpJAIMEhYlM130_provenance.
- assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP418689.RAcx1wMQHu8bhiXVZf90pzaGIPGOcwUJ5gaUoUOuEdf4w130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418689.RAcx1wMQHu8bhiXVZf90pzaGIPGOcwUJ5gaUoUOuEdf4w130_provenance.
- NP418683.RAlKVBGz2hkIUmeiy7ncqBFFqzyw-PSNnjJLnq2tPZyPI130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418683.RAlKVBGz2hkIUmeiy7ncqBFFqzyw-PSNnjJLnq2tPZyPI130_provenance.
- NP418685.RAgeLCb5DFki0rcaMRG0Dg59KHiiOul0CMsJ22HSPI9ak130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418685.RAgeLCb5DFki0rcaMRG0Dg59KHiiOul0CMsJ22HSPI9ak130_provenance.
- NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418686.RAtq3I-_Di-LcV_0UK5jIuf75uPSvfMmdHhvqJOy1vwNw130_provenance.
- NP418688.RAnq9zaZcbgga5BEpKyESX9QlmAUNKQklqjoNwPjBrT9A130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418688.RAnq9zaZcbgga5BEpKyESX9QlmAUNKQklqjoNwPjBrT9A130_provenance.
- NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP573917.RA3bPqVfwGfJIkCHfG-5lJ1-xuy5qTD2t3Efmb_Bleo94130_provenance.
- NP658433.RA_B4b-ZFjHFZEzD_wUdqZaAnTpHreBYufXym4llj01Ok130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658433.RA_B4b-ZFjHFZEzD_wUdqZaAnTpHreBYufXym4llj01Ok130_provenance.
- NP418687.RAOsS9nhQNP_-OyOGYIePWCQ6CyPsM457RReTH5WCUc3Y130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418687.RAOsS9nhQNP_-OyOGYIePWCQ6CyPsM457RReTH5WCUc3Y130_provenance.
- NP418684.RA3ZJCkWno9MVCA7KQz9wdi8ZtIkDV8Ty1LBAacSaHf9w130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418684.RA3ZJCkWno9MVCA7KQz9wdi8ZtIkDV8Ty1LBAacSaHf9w130_provenance.
- NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_assertion description "[Specifically, chemoprevention trials are currently ongoing to evaluate the efficacy of COX-2 inhibitors in the prevention of colorectal cancer in HNPCC and familial adenomatous polyposis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418690.RA-qZJ1XNc0Ng4YS9YY_fvldVozMPat38fZ-m_NiWar3Q130_provenance.